Skip to content
DraconiticResearch
Search Sources API
181,716 studies31 sourcesUpdated 49 min ago
Peer-reviewedLicence not statedBlood

IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas

  • Alberto J. Arribas1,2
  • Eleonora Cannas1
  • Giulio Sartori1
  • Francesca Guidetti1
  • Luciano Cascione1,2
  • Sara Napoli1
  • Gabriela Forestieri1
  • Federica Fuzio1
  • Emma Pesenti1
  • Chiara Tarantelli1
  • Filippo Spriano1
  • Antonella Zucchetto3
20 more authors
  • Francesca Maria Rossi3
  • Alessio Bruscaggin1
  • Andrea Rinaldi1
  • Manuel Castro de Moura4
  • Sandra Jovic5
  • Andrea Raimondi5
  • Roberta Bordone Pittau6
  • Lodovico Terzi di Bergamo1
  • Xiaofei Ye7
  • Anastasios Stathis6,8
  • Yaacov Ben‐David9,10
  • Qiang Pan‐Hammarström7
  • Federico Simonetta11,12
  • Georg Stüssi6
  • Emanuele Zucca1,6
  • Valter Gattei3
  • Jennifer R. Brown13
  • Manel Esteller14,15,16,4
  • Davide Rossi1,6
  • Francesco Bertoni1,6
16 affiliations
  1. 11Institute of Oncology Research, Faculty of Biomedical Sciences, Università della Svizzera italiana, Bellinzona, Switzerland
  2. 22Swiss Institute of Bioinformatics, Lausanne, Switzerland
  3. 33Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano Istituto di Ricovero e Cura a Carattere Scientifico, Aviano, Italy
  4. 44Josep Carreras Leukaemia Research Institute, Barcelona, Spain
  5. 55Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland
  6. 66Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland
  7. 77Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
  8. 88Faculty of Biomedical Sciences, Università della Svizzera italiana, Bellinzona, Switzerland
  9. 910The Natural Products Research Center of Guizhou Province, Guiyang, People's Republic of China
  10. 109State Key Laboratory for Discovery and Utilization of Functional Component in Traditional Chinese Medicine, Guizhou Medical University, Guiyang, People's Republic of China
  11. 1111Division of Haematology, Department of Oncology, Geneva University Hospitals, Geneva, Switzerland
  12. 1212Translational Research Center for Oncohematology, Department of Medicine and Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland
  13. 1313Chronic Lymphocytic Leukemia Center, Division of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA
  14. 1414Centro de Investigacion Biomedica en Red Cancer, Madrid, Spain
  15. 1515Institucio Catalana de Recerca i Estudis Avançats, Barcelona, Spain
  16. 1616Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain
Open at sourceDOICite

Related

  1. Impaired Erythropoietin Production in Liver Transplant Recipients: the Role of Calcineurin Inhibitors
    Valérie Bardet, Alcindo Pissaia Junior, Joël Coste +7
    Liver TransplantationPeer-reviewedLicence not statedFull text21 citedSurgery & anaesthesiaHAL
  2. Opportunities and challenges in the development of evolving EGFR inhibitors to overcome EGFR TKIs resistance
    Yi Chen, Qiu-pei Liu, Si-jie Yang +3
    Acta Pharmacologica SinicaPeer-reviewedLicence not statedFull text1 citedGeneral medicinePMC
  3. Heliocide H2 and cadinatriene glucopyranoside as promising dual β-lactamase inhibitors against antibiotic resistance: an integrated computational study
    Sana Noor, Vipin Kumar Mishra, Aqal Zaman +10
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicineCrossref
  4. The Role and Mechanism of SGLT2 Inhibitors in Chronic Kidney Disease
    Jiaqian Xie, Yuqi Liu, Yi Zhao +2
    Drug Design, Development and TherapyPeer-reviewedCC BY-NC 4.0Full textGeneral medicinePMC
  5. Mechanisms of Response and Resistance to Immune Checkpoint Inhibitors in Renal Cell Carcinoma
    Martina Milella, Francesco Lasorsa, Monica Rutigliano +5
    CellsPeer-reviewedCC BY 4.0OncologyCrossref

Cite

BibTeXRIS
BibTeX
@article{arribas2026il16,
  title = {{IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas}},
  author = {Alberto J. Arribas and Eleonora Cannas and Giulio Sartori and Francesca Guidetti and Luciano Cascione and Sara Napoli and Gabriela Forestieri and Federica Fuzio and Emma Pesenti and Chiara Tarantelli and Filippo Spriano and Antonella Zucchetto and Francesca Maria Rossi and Alessio Bruscaggin and Andrea Rinaldi and Manuel Castro de Moura and Sandra Jovic and Andrea Raimondi and Roberta Bordone Pittau and Lodovico Terzi di Bergamo and Xiaofei Ye and Anastasios Stathis and Yaacov Ben‐David and Qiang Pan‐Hammarström and Federico Simonetta and Georg Stüssi and Emanuele Zucca and Valter Gattei and Jennifer R. Brown and Manel Esteller and Davide Rossi and Francesco Bertoni},
  journal = {Blood},
  year = {2026},
  month = may,
  doi = {10.1182/blood.2025029956},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC13588736/},
}
RIS
TY  - JOUR
TI  - IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas
AU  - Alberto J. Arribas
AU  - Eleonora Cannas
AU  - Giulio Sartori
AU  - Francesca Guidetti
AU  - Luciano Cascione
AU  - Sara Napoli
AU  - Gabriela Forestieri
AU  - Federica Fuzio
AU  - Emma Pesenti
AU  - Chiara Tarantelli
AU  - Filippo Spriano
AU  - Antonella Zucchetto
AU  - Francesca Maria Rossi
AU  - Alessio Bruscaggin
AU  - Andrea Rinaldi
AU  - Manuel Castro de Moura
AU  - Sandra Jovic
AU  - Andrea Raimondi
AU  - Roberta Bordone Pittau
AU  - Lodovico Terzi di Bergamo
AU  - Xiaofei Ye
AU  - Anastasios Stathis
AU  - Yaacov Ben‐David
AU  - Qiang Pan‐Hammarström
AU  - Federico Simonetta
AU  - Georg Stüssi
AU  - Emanuele Zucca
AU  - Valter Gattei
AU  - Jennifer R. Brown
AU  - Manel Esteller
AU  - Davide Rossi
AU  - Francesco Bertoni
PY  - 2026
DA  - 2026/05/29
JO  - Blood
DO  - 10.1182/blood.2025029956
UR  - https://pmc.ncbi.nlm.nih.gov/articles/PMC13588736/
SN  - 0006-4971
SN  - 1528-0020
ER  -